A Clinical Study to Access the Pharmacokinetics of HMS5552 in Hepatic Impaired Subjects and Healthy Volunteers
Status:
Recruiting
Trial end date:
2020-09-01
Target enrollment:
Participant gender:
Summary
The objectives of this study is to access the pharmacokinetics and safety of HMS5552 in
single dose in mild and moderate hepatic impaired subjects and matched healthy adult
subjects.